Coverage
-
February 22, 2016
Enzo Biochem Inc. lost its bid to revive a $61 million damages and interest verdict that its patent for labeling and detecting DNA was infringed when a Connecticut federal judge on Monday found that the Federal Circuit had doomed the claims in a "somewhat cryptic mandate."
4 other articles on this case.
View all »